Jury orders Olympus to pay hospital $6.6 million but rejects claims scopes are unsafe

Hospital must pay $1 million to deceased patient’s family


A jury ordered Olympus Corp. to pay a Seattle hospital $6.6 million in damages tied to a deadly superbug outbreak, and told the hospital to pay $1 million to a deceased patient’s family, according to an article on the Los Angeles Times website.

But the jurors rejected claims that the company’s flagship medical scope was unsafe as designed.

The case was filed by Theresa Bigler, 61, and her four children in connection with the August 2013 death of Richard Bigler, a pancreatic cancer patient who contracted an infection linked to a contaminated Olympus TJF-Q180V duodenoscope. 

Virginia Mason Medical Center later joined the suit against Olympus, but the jury found it shared some blame in the case.

Read the article.

 



July 31, 2017


Topic Area: Infection Control


Recent Posts

What Lies Ahead for Healthcare Facilities Managers

Staffing shortages, rising regulatory scrutiny and accelerating adoption of AI are converging to reshape the way healthcare facilities are managed.


What's in the Future for Healthcare Restrooms?

Workforce shortages, rising hygiene expectations and connected technologies are pushing healthcare restrooms beyond basic utility.


Hammes Completes the Moffit Speros Outpatient Center

The new outpatient center will provide infusion services, clinical space, radiology and radiation oncology.


The Top Three Pathogens to Worry About in 2026

Key viruses to watch out for and how to prevent them.


Blackbird Health Opens New Pediatric Mental Health Clinic in Virginia

It offers comprehensive evaluations, therapy and medication management under one roof.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.